CMV colitis: Difference between revisions

(Text replacement - "==Diagnosis==" to "==Evaluation==")
No edit summary
Line 6: Line 6:


==Clinical Features==
==Clinical Features==
*Fever
*[[Fever]]
*Anorexia
*Anorexia
*Malaise
*Malaise
Line 12: Line 12:
*Dehydration
*Dehydration
*Abdominal pain
*Abdominal pain
*Abdominal distention
*Abdominal distention, [[constipation]]
*Nausea
*[[Nausea/vomiting]]
*Vomiting
*Chronic watery [[diarrhea]]
*Chronic watery diarrhea
*Bloody diarrhea
*Bloody diarrhea
*Constipation
*Worsening symptoms of inflammatory bowel disease
*Worsening symptoms of inflammatory bowel disease


Line 28: Line 26:


==Management==
==Management==
{{CMV colitis treatment}}


==Disposition==
==Disposition==
{{CMV colitis treatment}}
==See Also==
==See Also==
*[[Cytomegalovirus (CMV) infection]]
*[[Cytomegalovirus (CMV) infection]]

Revision as of 00:03, 26 February 2017

Background

  • CMV is part of the Herpesviridae family
  • 50-80% of the world's population is seropositive for CMV
  • Causes a mild or undetectable infection in immunocompetent hosts
  • Severe systemic illness is found in immunosuppressed hosts

Clinical Features

  • Fever
  • Anorexia
  • Malaise
  • Weight loss
  • Dehydration
  • Abdominal pain
  • Abdominal distention, constipation
  • Nausea/vomiting
  • Chronic watery diarrhea
  • Bloody diarrhea
  • Worsening symptoms of inflammatory bowel disease

Differential Diagnosis

Colitis

CMV Diseases

Evaluation

Management

  • Ganciclovir 5mg/kg IV q12hrs x 21 days (or until resolution of symptoms)
  • Foscarnet 90mg/kg IV q12hrs daily x 21 days (or until resolution of symptoms)

Disposition

See Also

External Links

References